Close

Abiomed, Inc. (ABMD) Tops Q4 EPS by 1c

May 1, 2014 7:43 AM EDT

Abiomed, Inc. (NASDAQ: ABMD) reported Q4 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $50.4 million versus the consensus estimate of $50.93 million.

For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings